微囊性附件癌的临床试验
总计25714个结果
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Marker Therapeutics, Inc.完全的
-
Duke UniversityJohns Hopkins University; Genentech, Inc.完全的
-
Institut BergoniéRoche Pharma AG; Ligue contre le cancer, France完全的
-
University College, LondonMedical Research Council; Cancer Research UK; National Institute for Health Research, United Kingdom 和其他合作者完全的
-
University of South AlabamaMayo Clinic; Washington University School of Medicine; Tulane University Health Sciences Center; Augusta University 和其他合作者完全的
-
Vastra Gotaland RegionThe Swedish Research Council; Sahlgrenska University Hospital, Sweden; Swedish Cancer Society完全的
-
Shenzhen Geno-Immune Medical Institute未知
-
Zhejiang UniversitySecond Affiliated Hospital, School of Medicine, Zhejiang University; Hrain Biotechnology Co....未知
-
Hillel Yaffe Medical Center未知
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)终止
-
M.D. Anderson Cancer CenterGenentech, Inc.完全的
-
Memorial Sloan Kettering Cancer CenterJohns Hopkins University; M.D. Anderson Cancer Center完全的
-
Hoffmann-La Roche完全的卵巢癌法国, 西班牙, 巴西, 英国, 荷兰, 意大利, 俄罗斯联邦, 瑞典, 挪威
-
Samyang Biopharmaceuticals Corporation完全的
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)完全的
-
Janssen Research & Development, LLC完全的
-
Massachusetts General HospitalWomen and Infants Hospital of Rhode Island完全的
-
Mackay Memorial HospitalOBI Pharma, Inc未知
-
University of Alabama at BirminghamNational Cancer Institute (NCI)撤销
-
Memorial Sloan Kettering Cancer Center完全的
-
Achieve Life Sciences完全的